Rankings
▼
Calendar
NAUT Q4 2024 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$6M
Operating Income
-$20M
Net Income
-$18M
EPS (Diluted)
$-0.14
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$15M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$243M
Total Liabilities
$34M
Stockholders' Equity
$209M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$6M
-$2M
-299.6%
Operating Income
-$20M
-$20M
+0.1%
Net Income
-$18M
-$17M
-3.3%
← FY 2024
All Quarters
Q1 2025 →